← Back to Search

Vestibular Stimulation for Motion Sickness

N/A
Recruiting
Led By Gaurav Pradhan, PhD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants must be able to consent to participate themselves and be 21 to 55 years of age
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after each flight stimulation session, approximately 1 hour
Awards & highlights

Study Summary

This trial aims to develop tech to reduce motion sickness from virtual reality, helping people experience VR more comfortably.

Who is the study for?
This trial is for English-speaking adults aged 21 to 55 who can attend sessions in Scottsdale, AZ. It's not for those with vestibular diseases, migraines, severe balance or motion sensitivity issues, or pregnant women.Check my eligibility
What is being tested?
The study tests a new wearable device designed to reduce VR-induced motion sickness using Galvanic Vestibular Stimulation (GVS), alongside flight simulations and balance assessments on a force plate system.See study design
What are the potential side effects?
Potential side effects may include discomfort from the GVS device, dizziness during or after stimulation, nausea related to VR simulation, and fatigue from participation in the study activities.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 21 and 55 years old and can consent to participate.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after balance testing in each session, approximately 1 hour
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after balance testing in each session, approximately 1 hour for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
COG Sway velocity
Pensacola Diagnostic Index-based motion sickness questionnaire

Trial Design

6Treatment groups
Experimental Treatment
Group I: Positive GVS During VR Flight SimulationExperimental Treatment2 Interventions
Subjects will receive positive galvanic vestibular stimulation (GVS) during a flight simulation in virtual reality (VR).
Group II: Positive GVS During 3-DOF Bertec Portable Essential's dual-balance force plate systemExperimental Treatment2 Interventions
Subjects will receive positive galvanic vestibular stimulation (GVS) while utilizing the 3-DOF Bertec Portable Essential's dual-balance force plate system.
Group III: No GVS During VR Flight SimulationExperimental Treatment1 Intervention
Subjects will not receive any galvanic vestibular stimulation (GVS) during a flight simulation in virtual reality (VR).
Group IV: No GVS During 3-DOF Bertec Portable Essential's dual-balance force plate systemExperimental Treatment1 Intervention
Subjects will not receive any galvanic vestibular stimulation (GVS) while utilizing the 3-DOF Bertec Portable Essential's dual-balance force plate system.
Group V: Negative GVS During VR Flight SimulationExperimental Treatment2 Interventions
Subjects will receive negative galvanic vestibular stimulation (GVS) during a flight simulation in virtual reality (VR).
Group VI: Negative GVS During 3-DOF Bertec Portable Essential's dual-balance force plate systemExperimental Treatment2 Interventions
Subjects will receive negative galvanic vestibular stimulation (GVS) while utilizing the 3-DOF Bertec Portable Essential's dual-balance force plate system.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,216 Previous Clinical Trials
3,767,448 Total Patients Enrolled
1 Trials studying Motion Sickness
29 Patients Enrolled for Motion Sickness
Gaurav Pradhan, PhDPrincipal InvestigatorMayo Clinic
2 Previous Clinical Trials
25 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it permissible for me to register in this experiment?

"This study is accepting 40 applicants aged 21 to 55 who suffer from motion sickness."

Answered by AI

Is this research opportunity available for participants at the moment?

"As per information on clinicaltrials.gov, this medical trial is now recruiting volunteers and the posting has been updated as recently as October 24th 2023 (having first gone live on November 1st 2023)."

Answered by AI

Is this research program open to participants who are over a quarter-century of age?

"This medical study is only open to participants aged 21-55. For those under the age of 18 and over 65, there are other clinical trials available with 1 and 4 studies respectively."

Answered by AI

What is the ceiling for participant involvement in this experiment?

"Affirmative. Information on clinicaltrials.gov demonstrates that this medical experiment is currently enrolling participants. The trial was first advertised on November 1st 2023 and its details were recently adjusted on October 24th 2023, with the aim of recruiting 40 patients from a single location."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Three-Axis Wearable Adaptive Vestibular Stimulator
Gaurav N. Pradhan 2023. "Three-Axis Wearable Adaptive Vestibular Stimulator". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06106256.
All > Motion Sickness
~7 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top